MedTrace Logo

Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit)

NCT03695770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3733

Last updated 2021-05-20

No results posted yet for this study

Summary

Illegal gold miners in French Guiana, a French overseas territory ('département') located in Amazonia, often carry malaria parasites (up to 46.8%). While the Guiana Shield Region aims at malaria elimination, the high prevalence of Plasmodiumin this hard-to-reach population in conjunction with frequent incorrect use of artemisinin-based anti-malarials could favor the emergence of resistant parasites. Due to geographical and regulatory issues in French Guiana, usual malaria control strategies cannot be implemented in this particular context.Therefore, new strategies targeting this specific population in the forest are required.

Numerous discussions among health institutions and scientific partners from French Guiana, Brazil and Suriname have led to an innovative project based on the distribution of kits for self-diagnosis and self-treatment of Plasmodium infections. The kit-distribution will be implemented at "resting sites", which are areas across the border of French Guiana regularly frequented by gold miners. The main objective is to increase the appropriate use and complete malaria treatment after a positive malaria diagnosis with a rapid test, which will be evaluated with before-and-after cross-sectional studies. Monitoring indicators will be collected from health mediators at the time of kit distribution and during subsequent visits, and from illegal gold miners themselves, through a smartphone application. The project funding is multisource, including Ministries of Health of the three countries, WHO/PAHO, and the European Union.

Conditions

Interventions

OTHER

kit for self-diagnosis and self-treatment

distribution of kits for malaria self-diagnosis and self-treatment after a training by health facilitators

Sponsors & Collaborators

  • Dr Stephen Vreden (Foundation for Scientific Research Suriname : SWOS)

    collaborator UNKNOWN

  • Oswaldo Cruz Foundation

    collaborator OTHER

  • Dr Maylis Douine (Centre Hospitalier de Cayenne)

    collaborator UNKNOWN

  • Centre Hospitalier de Cayenne

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-16
Primary Completion
2020-03-30
Completion
2020-03-30

Countries

  • Brazil
  • Suriname

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695770 on ClinicalTrials.gov